Jump to section
To accelerate regulated digital health innovation for our biopharma and medtech customers through our scalable medical-grade platform.
Using software for medical purposes is a twofold challenge, companies must ensure that they are complying with both security requirements and healthcare regulations. Medical software development often spans several teams within businesses as well as possibly external specialists and consultants.
BrightInsight aids clients by providing guidance for the development of new software. It responds to legislative changes and keeps customers updated, freeing up resources, letting clients focus on patient care, and improving their drug development time to market.
BrightInsight has already worked with big names, such as AstraZeneca and CSL Behring. The company created a dosing calculator to help with the treatment of hemophilia, BrightInsight was able to design, develop, and bring the software to market in about six months, considerably less than the industry standard.
Freddie
Company Specialist at Welcome to the Jungle
Mar 2021
$101m
SERIES C
Jun 2020
$40m
SERIES B
This company has top investors
Kal Patel
(Co-founder & CEO)Kal worked at BCG for over 5 years before working at NOVARTIS and founding Amgen. He served as President of Flex Digital and Senior Digital Health Advisor at BCG before co-founding BrightInsight in January 2019.
Ferry Tamtoro
(Co-founder)Previously Ferry was a Technical Project Manager at GE Healthcare, a Product Manager at Walgreens and a Director for Digital Health Products at Amgen.